Metabolism of amprenavir in liver microsomes: role of CYP3A4 inhibition for drug interactions

Journal of Pharmaceutical Sciences
C J DeckerP R Chaturvedi

Abstract

Amprenavir (141W94, VX-478, KVX-478) is metabolized primarily by CYP3A4 (cytochrome P450 3A4) in recombinant systems and human liver microsomes (HLM). The effects of ketoconazole, terfenadine, astemizole, rifampicin, methadone, and rifabutin upon amprenavir metabolism were examined in vitro using HLM. Ketoconazole, terfenadine, and astemizole were observed to inhibit amprenavir depletion, consistent with their known specificity for CYP3A4. The HIV protease inhibitors, indinavir, saquinavir, ritonavir, and nelfinavir, were included in incubations containing amprenavir to examine the interactions of HIV protease inhibitors in vitro. The order of amprenavir metabolism inhibition in human liver microsomes was observed to be: ritonavir > indinavir > nelfinavir > saquinavir. The Ki value for amprenavir-mediated inhibition of testosterone hydroxylation in human liver microsomes was found to be approximately 0.5 microM. Studies suggest that amprenavir inhibits CYP3A4 to a greater extent than saquinavir, and to a much lesser extent than ritonavir. Amprenavir, nelfinavir, and indinavir appear to inhibit CYP3A4 to a moderate extent, suggesting a selected number of coadministration restrictions.

Citations

Nov 28, 2007·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Dhananjay Pal, Ashim K Mitra
Nov 9, 2006·Current HIV/AIDS Reports·Paula J Lum, Jacqueline Peterson Tulsky
Jul 8, 2009·Applied Biochemistry and Biotechnology·Sepuri Asha, Maravajhala Vidyavathi
Jun 27, 2000·Clinical Therapeutics·H B FungR Hameed
Jun 6, 2000·Advanced Drug Delivery Reviews·G C Williams, P J Sinko
Jan 22, 2003·British Journal of Clinical Pharmacology·Ulrik S JustesenCourt Pedersen
Mar 10, 2004·AIDS Patient Care and STDs·Natella Y RakhmaninaSteven J Soldin
Feb 14, 2007·Antimicrobial Agents and Chemotherapy·Isabelle PellegrinUNKNOWN ANRS Co3 Aquitaine Cohort
Mar 18, 2000·Antimicrobial Agents and Chemotherapy·D F BrophyR E Polk
Feb 13, 2001·Antimicrobial Agents and Chemotherapy·R E PolkD S Stein
Dec 25, 2002·Antimicrobial Agents and Chemotherapy·Marc PfisterUNKNOWN Adult AIDS Clinical Trial Group Study 398
Mar 24, 2004·Inflammopharmacology·Costas Ioannides
Mar 10, 2000·Clinical Pharmacokinetics·K VenkatakrishnanD J Greenblatt
Aug 5, 2000·Clinical Pharmacokinetics·E L Michalets, C R Williams
May 1, 2001·Clinical Pharmacokinetics·J Q TranB M Kerr
Feb 27, 2003·Clinical Pharmacokinetics·Monique M R de MaatJos H Beijnen
Mar 15, 2005·Clinical Pharmacokinetics·Shufeng ZhouHoward L McLeod
May 25, 2005·Clinical Pharmacokinetics·Jeffrey S BarrettMarc Pfister
Nov 1, 2011·Critical Reviews in Clinical Laboratory Sciences·Bhushan M KapurPeter Selby
Feb 5, 2002·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·V A EaglingD J Back
Nov 4, 2000·Expert Opinion on Investigational Drugs·B Conway, S D Shafran
Nov 12, 2005·Substance Use & Misuse·Joy C Draper, Elinore F McCance-Katz
May 9, 2002·Drug Metabolism Reviews·Slobodan Rendic
Mar 8, 2005·Drug Metabolism Reviews·Shufeng ZhouYu-Zong Chen
May 6, 2010·Drug Metabolism Reviews·Federica VacondioBernard Testa
Aug 6, 2002·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·C Ioannides
Jul 28, 2015·Journal of Pharmaceutical Sciences·Tom De BruynPieter P Annaert
May 17, 2011·The Lancet Oncology·Michelle A RudekRichard F Ambinder
Jan 26, 2006·Basic & Clinical Pharmacology & Toxicology·Marika T GranforsJanne T Backman
Jan 31, 2006·Life Sciences·Dhananjay Pal, Ashim K Mitra
Jan 9, 2004·Infectious Disease Clinics of North America·Sandra L PrestonGeorge L Drusano
Mar 11, 2005·Expert Opinion on Pharmacotherapy·Sarah M RobertsonAlice K Pau
Apr 18, 2017·Journal of Pharmaceutical Sciences·Jingjing YuIsabelle Ragueneau-Majlessi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.